Editorial Comment from Dr Yamanishi to Long ‐term safety and efficacy of the novel β3‐adrenoreceptor agonist vibegron in Japanese patients with overactive bladder: A phase III prospective study
International Journal of Urology, EarlyView.
Source: International Journal of Urology - Category: Urology & Nephrology Authors: Tomonori Yamanishi M.D. Source Type: research
More News: Japan Health | Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology